Natera

Natera

Biotechnology Research

Austin, Texas 150,726 followers

We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.

About us

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.  Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients. #TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/

Website
http://www.natera.com
Industry
Biotechnology Research
Company size
1,001-5,000 employees
Headquarters
Austin, Texas
Type
Public Company
Founded
2004
Specialties
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA

Locations

Employees at Natera

Updates

  • View organization page for Natera, graphic

    150,726 followers

    Congratulations to Jess Lee on her participation in the White House’s Conference on Women’s Health Research. We appreciate your support of Natera and were honored to be recognized alongside such inspiring companies in the Women’s Health space. Thank you for sharing insights on this thoughtful discussion!

    View profile for Jess Lee, graphic

    Partner at Sequoia Capital / Co-Founder & CEO of Polyvore

    It was such a cool life experience to have been invited to speak at The White House’s Conference on Women’s Health Research, hosted by Dr. Jill Biden and President Joe Biden. The White House convened an incredible group of people across industry, academia, policy and non-profits to talk about the future of women’s health. The energy in the room was electric. On our panel about the business of investing in women's health, I shared how women’s health is surprisingly underhyped given its market size: half of humanity. Women’s health is a market that hides in plain sight, in the blind spot of VC demographics. People invest in what they know, and since venture is 17% women, the category has been been historically underfunded. Other markets that had blind spots due to lack of personal experience by VCs were defense tech and consumer social circa 2004-2008. Over the years, Sequoia has had the privilege of partnering with several great companies touching women’s and family health, including: - Natera was founded by Matthew Rabinowitz to develop better technologies to detect prenatal genetic conditions. Today, Natera’s non-invasive prenatal test is ordered by half of all OB/GYNs in the US, and under the leadership of CEO Steve Chapman has also expanded into oncology. Roelof Botha led their seed and has been on their board for 18 years. The company is now worth $22B. - Maven Clinic was founded by Kate Ryder and today is the largest virtual clinic for women’s and family health, spanning maternity, fertility, pediatrics, parenting, and menopause. It’s an employee benefit used by half the Fortune 15, including Amazon, Google, JP Morgan, Microsoft, and UnitedHealth Group. Kate is a force of nature and it’s been a huge honor serving on her board. Maven announced new funding at a $1.7B valuation a few months ago. - Roon tackles misinformation in healthcare by offering answers directly from world-class health experts and doctors. Co-founded by Vikram Bhaskaran, Rohan Ramakrishna, MD, and Arun Ranganathan, their video Q&A platform has 16K short-form videos from doctors in women's and reproductive health, ALS, and dementia. - Summer Health is a 24/7 pediatrics and parenting hotline co-founded by Ellen D. and Matthew Woo. It’s a lifesaver in those emergency situations. When pioneering founders build enormous businesses in these “blind spot” categories, that success breeds more success. We need first believers – including investors and policymakers – to help move money, shift power, and change culture (h/t All Raise). Thank you to The White House for hosting such a wonderful gathering, to our moderator Trish Stroman and my fellow panelists Jyoti Gupta, Stephanie Sassman and Johanna Grossman, PhD for a thoughtful discussion, and to Alex Friedman (a former women's health founder herself, of LOLA - mylola.com) for inviting me! You can watch the event here: https://lnkd.in/e6j5P8wf

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Natera, graphic

    150,726 followers

    Be sure to watch Matthew Rabinowitz's R&D Leader of the Year acceptance speech below. He expresses gratitude for the accomplishments of the Natera team and highlights opportunities to strengthen our nation and economy through healthcare innovation.

  • Natera reposted this

    📚 New publication alert! 📚 We’re thrilled to announce that our clinical validation study on our Fetal RhD NIPT has been published by Obstetrics and Gynecology (The Green Journal)! 🙌 This is the largest study of its kind in the U.S., and Natera's Fetal RhD NIPT demonstrated excellent performance with sensitivity of 100% and specificity of 99.3%. “This large clinical validation study demonstrated excellent performance in identification of fetal RhD status,” said Marisa Gilstrop Thompson, M.D., a board-certified physician in Maternal Fetal Medicine, Obstetrics and Gynecology, and Clinical Genetics with the Delaware Center for Maternal and Fetal Medicine of Christiana Care. “Access to highly accurate fetal RhD testing has the potential to transform the care of RhD-negative pregnant patients.” #NIPT #RhD #Natera

  • View organization page for Natera, graphic

    150,726 followers

    We're excited to share that our co-founder and executive chairman, Matthew Rabinowitz, PhD, has been named R&D Leader of the Year by R&D - Research & Development World! In awarding this honor, R&D World referred to Dr. Rabinowitz as a “pioneering figure in genetic testing and precision medicine.” The organization cited numerous achievements throughout his career at Natera, highlighting the company’s efforts to shape how diseases are detected and managed globally. When accepting the award, Dr. Rabinowitz congratulated fellow R&D Award winners and noted that this recognition was "largely thanks to the dedicated teams who have transformed fields such as women’s health and cancer care." 👏 Read more in our latest press release: https://ow.ly/NaEe50Uf51G #Natera #RD100

    • No alternative text description for this image
  • View organization page for Natera, graphic

    150,726 followers

    We're proud to share that we hit our 2025 volunteerism goal early, successfully contributing 20,000 volunteer hours, honoring our core value "be ready to change the world." During our annual Volunteer Month in October, Naterans all over the country gave the gift of time in various ways – writing letters with Vote Forward to encourage voter turnout, supporting racers at the Susan G. Komen events in Austin and San Francisco, assembling "Kynd Kits" for nonprofit partners through Project Helping, and so much more – and have truly made a difference.

  • Natera reposted this

    View organization page for Natera Oncology, graphic

    16,979 followers

    Key milestone surpassed: Over 100 peer-reviewed publications on Signatera, our personalized and tumor-informed molecular residual disease (MRD) test. “Natera has always had a focus on developing robust clinical evidence,” said Alexey Aleshin, MD, chief medical officer and general manager of oncology. “The ongoing delivery of high-quality data is critical to our mission as we work to positively impact cancer care for patients and their families. We want to thank our patients for participating in these studies and our collaborators for their partnership on these efforts.” Multiple validation studies on Signatera have been published in top-tier journals like @Nature, Nature Medicine, Nature Cancer, Journal of Clinical Oncology, Annals of Research in Oncology, and JAMA Oncology. These include some of the largest and most comprehensive prospective studies of MRD testing to date. https://ow.ly/z6t850UcUim #Natera #MRDTesting #Signatera

    Natera Announces Publication of over 100 Peer-Reviewed Papers on Signatera™

    Natera Announces Publication of over 100 Peer-Reviewed Papers on Signatera™

    natera.com

  • View organization page for Natera, graphic

    150,726 followers

    Over nearly two decades, we've demonstrated that mission-driven entrepreneurship can revolutionize healthcare. By bridging engineering, biology, and genetics, our team has expanded from IVF to transformative diagnostics in prenatal care, oncology, and organ health. Our journey proves that constraints can be catalysts for innovation, and believing in scientific integrity is the ultimate competitive advantage. Hear more from our founders Matthew Rabinowitz and Jonathan Sheena, plus CEO Steve Chapman, and Naterans Chitra Kotwaliwale, Ph.D. and Sarah Elliott (Berridge) in this Crucible Moments podcast episode from Sequoia Capital. https://ow.ly/HASF50UbK1F

    Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution

    Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution

    https://www.sequoiacap.com

  • View organization page for Natera, graphic

    150,726 followers

    Today, we celebrate genetic counselors! 🧬 We're especially proud of the incredible team of over 150 genetic counselors (GCs) at Natera. These highly-trained professionals provide support to patients and families navigating genetic testing – with empathy as the cornerstone of every interaction. 💙💚 In addition to patient-facing roles, our GCs apply their diverse skills across the company, contributing to business development, research, training, and more. Natera GCs also support the GC community through educational events such as exam study groups, professional development opportunities, and resume clinics. Thank you, GCs, for all that you do! 👏 https://ow.ly/4fib50U71WA #GeneticCounselors #PatientCare #GCAwarenessDay #Natera

    • No alternative text description for this image
  • View organization page for Natera, graphic

    150,726 followers

    Are you interested in becoming a genetic counselor or have a desire to learn about lab-based genetic counseling roles? 🧬🥼🔬 Please join us for a webinar exploring some of the roles that genetic counselors may have working for a commercial lab. This event will feature four panelists who are eager to discuss their various roles and how their career path led them to #Natera. #GeneticCounselor Wednesday, November 13 4 PM ET | 1 PM PT View the full details below and register today: https://ow.ly/JuLb50U1OS5

  • View organization page for Natera, graphic

    150,726 followers

    #Natera co-founder and executive chairman of the board, Matthew Rabinowitz, PhD, has been named a finalist in the Leadership category for the California Life Sciences (CLS) Pantheon Award. The award recognizes leaders who innovate in life sciences, demonstrating commitment to positive global impact and support for patient-centric initiatives. Winners are selected by public voting now through October 15th. Please cast your vote at https://lnkd.in/eGPkm4xA by selecting the leadership category at the bottom. #PantheonAwards

Affiliated pages

Similar pages

Browse jobs

Stock

NTRA

NASDAQ

20 minutes delay

$161.88

3.79 (2.397%)

Open
154.68
Low
154.01
High
163.05

Data from Refinitiv

See more info on Bing

Funding

Natera 14 total rounds

Last Round

Post IPO equity

US$ 250.0M

See more info on crunchbase